Publication | Open Access
RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
22
Citations
34
References
2022
Year
These findings suggest that RB1 was a novel and immune-related prognostic biomarker for OC, which may be a promising target for OC treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1